On the occasion of World Malaria Day 2014, Novartis announced a new partnership with the University of California San Francisco’s (UCSF) Global Health Group, the Multi-disciplinary Research Centre at the University of Namibia (UNAM) and the National Vector-borne Disease Control Program (NVDCP) at the Ministry of Health and Social Services (MoHSS) of Namibia. The partnership will conduct research, including capacity building and technical assistance, on Targeted Parasite Elimination (TPE) in the Zambezi region in northeastern Namibia.
TPE is a new strategy to empty the reservoir of malaria parasites maintained by asymptomatic carriers in low malaria settings. The program aims at building evidence on the operational feasibility for potential TPE implementation by national malaria control programs.
This new partnership will determine the suitability of TPE, using artemisinin combination therapy (ACT), as a new malaria elimination strategy in pre-elimination settings, such as Namibia. The program aims at building evidence on the operational feasibility for potential implementation by national malaria control programs.
|Location||Southern Africa, Namibia|